7301 - 7325 of 8112 Results
Title
Year
- Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats2013OPENTitle: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017Best OA location URL: https://europepmc.org/articles/pmc3865178?pdf=renderCitation Count: 63
-
OPENTitle: Autonomic complaints in patients with restless legs syndromeJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 14Issue #: 12Start Page: 1413End Page: 1416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2013.08.781Best OA location URL: https://europepmc.org/articles/pmc4105217?pdf=renderCitation Count: 31
- Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s disease2013OPENTitle: Thalamic cholinergic innervation and postural sensory integration function in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 136Issue #: 11Start Page: 3282End Page: 3289Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awt247Best OA location URL: https://academic.oup.com/brain/article-pdf/136/11/3282/11138755/awt247.pdfCitation Count: 167
-
OPENTitle: Continuous in-home monitoring of essential tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 1Start Page: 37End Page: 40Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.09.009Best OA location URL: https://europepmc.org/articles/pmc3946846?pdf=renderCitation Count: 66
-
OPENTitle: Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive PhosphateJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 79Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/50523Best OA location URL: https://europepmc.org/articles/pmc3923590?pdf=renderCitation Count: 4
-
OPENTitle: Metabolomics and the search for biomarkers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1620End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25644Best OA location URL: https://europepmc.org/articles/pmc4050667?pdf=renderCitation Count: 9
-
RESTRICTEDTitle: The Evolving Role of Diffusion Magnetic Resonance Imaging in Movement DisordersJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-013-0400-1Best OA location URL: https://europepmc.org/articles/pmc3824956?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Imaging: What can it tell us about parkinsonian gait?Journal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 11Start Page: 1492End Page: 1500Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25534Best OA location URL: https://europepmc.org/articles/pmc3801220?pdf=renderCitation Count: 76
-
OPENTitle: Cheek cell–derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from controlJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 2Start Page: 418End Page: 420Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.08.008Best OA location URL: https://escholarship.org/content/qt8m97s2kf/qt8m97s2kf.pdf?t=rsqp1sCitation Count: 30
- Screening for early detection of parkinsonism using a self-administered questionnaire: A cross-sectional epidemiologic study2013OPENTitle: Screening for early detection of parkinsonism using a self-administered questionnaire: A cross-sectional epidemiologic studyJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 45Issue #:Start Page: 232End Page: 237Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2013.08.010Best OA location URL: https://europepmc.org/articles/pmc3954448?pdf=renderCitation Count: 5
- Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease2013OPENTitle: Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 1Start Page: 13End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.08.021Best OA location URL: https://europepmc.org/articles/pmc3946835?pdf=renderCitation Count: 8
- Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A2013RESTRICTEDTitle: Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1AJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 136Issue #: 10Start Page: 3140End Page: 3150Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awt233Best OA location URL: https://academic.oup.com/brain/article-pdf/136/10/3140/13796025/awt233.pdfCitation Count: 168
- Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients2013OPENTitle: Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 2039End Page: 2040Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25637Best OA location URL: https://europepmc.org/articles/pmc3859714?pdf=renderCitation Count: 7
- Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study2013OPENTitle: Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 10Start Page: 978End Page: 988Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70210-2Best OA location URL: https://europepmc.org/articles/pmc3879782?pdf=renderCitation Count: 259
-
OPENTitle: Parkinsonism syndrome in heterozygotes for Niemann–Pick C1Journal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 335Issue #: 1-2Start Page: 219End Page: 220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2013.08.033Best OA location URL: https://europepmc.org/articles/pmc4729292?pdf=renderCitation Count: 65
- 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model2013RESTRICTEDTitle: 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease modelJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 60Issue #:Start Page: 108End Page: 114Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.08.014Citation Count: 50
- Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian models2013RESTRICTEDTitle: Gene–environment interactions in Parkinson's disease: Specific evidence in humans and mammalian modelsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 57Issue #:Start Page: 38End Page: 46Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.06.025Best OA location URL: https://europepmc.org/articles/pmc3815566?pdf=renderCitation Count: 152
- Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s Disease2013OPENTitle: Microglial Beclin 1 Regulates Retromer Trafficking and Phagocytosis and Is Impaired in Alzheimer’s DiseaseJournal Name: NeuronPublisher: Elsevier BVVol: 79Issue #: 5Start Page: 873End Page: 886Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuron.2013.06.046Best OA location URL: http://www.cell.com/article/S089662731300562X/pdfCitation Count: 342
- P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s disease2013RESTRICTEDTitle: P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s diseaseJournal Name: Neuromuscular DisordersPublisher: Elsevier BVVol: 23Issue #: 9-10Start Page: 836End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nmd.2013.06.684Citation Count: 1
- Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo2013OPENTitle: Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivoJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 110Issue #: 41Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1309991110Best OA location URL: https://www.pnas.org/content/pnas/110/41/E3945.full.pdfCitation Count: 163
- Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease2013OPENTitle: Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.3861Best OA location URL: https://europepmc.org/articles/pmc4034348?pdf=renderCitation Count: 354
-
OPENTitle: Insight into α-Synuclein Plasticity and Misfolding from Differential Micelle BindingJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 117Issue #: 39Start Page: 11448End Page: 11459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jp402589xBest OA location URL: https://europepmc.org/articles/pmc3946565?pdf=renderCitation Count: 11
- Pesticides that inhibit the ubiquitin–proteasome system: Effect measure modification by genetic variation in SKP1 in Parkinson׳s disease2013OPENTitle: Pesticides that inhibit the ubiquitin–proteasome system: Effect measure modification by genetic variation in SKP1 in Parkinson׳s diseaseJournal Name: Environmental ResearchPublisher: Elsevier BVVol: 126Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.envres.2013.08.001Best OA location URL: https://escholarship.org/content/qt3295g553/qt3295g553.pdf?t=no8lj2Citation Count: 48
-
RESTRICTEDTitle: MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat modelJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 553Issue #:Start Page: 153End Page: 158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.08.001Citation Count: 60
- The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants2013OPENTitle: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 1Start Page: 266.e5End Page: 266.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013Best OA location URL: https://research-repository.griffith.edu.au/bitstream/10072/67208/1/MellickPUB29.pdfCitation Count: 37